Sort by
Refine Your Search
-
with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by
-
prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA
-
including quantum field theory in curved spacetime and related topics. This position is funded by the National Science Centre of Poland, under the MAESTRO grant "Elementary Particles in Curved Spacetime
-
suffer from genetic diseases. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers
-
foundation of any diabetes management plan, so we’re committed to continuous improvement in the way patients and professionals measure, track and analyze glucose levels. Our science-driven products empower
-
materials to ensure compliance with FDA and global regulations. Collaboration with cross-functional Promotional Review Committees (PRC/MLR). Gain experience with regulatory requirements for promotional
-
Details Posted: Unknown Location: Salary: Summary: Summary here. Details Posted: 18-Oct-25 Location: Boston, Massachusetts Type: Full-time Categories: Academic/Faculty Pharmaceutical Sciences
-
, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Clinical Science fellowship, based in Cambridge, MA. About Alnylam Alnylam
-
materials, sponsorships, grants. Fellow activity will often involve working cross-functionally with teams outside of Medical Affairs including Legal/Compliance, Sales & Marketing, Market Access/HEOR, Patient
-
Details Posted: Unknown Location: Salary: Summary: Summary here. Details Posted: 16-Sep-25 Location: Boston, Massachusetts Type: Full-time Categories: Academic/Faculty Physical Sciences Internal